Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
92.50
-1.71 (-1.82%)
At close: Apr 23, 2025
279.41%
Market Cap 20.10B
Revenue (ttm) 13.19B
Net Income (ttm) 821.88M
Shares Out 228.46M
EPS (ttm) 3.60
PE Ratio 24.45
Forward PE n/a
Dividend 3.25 (3.51%)
Ex-Dividend Date n/a
Volume 3,451,888
Average Volume 6,324,264
Open 94.30
Previous Close 94.21
Day's Range 92.00 - 94.90
52-Week Range 24.11 - 109.30
Beta 0.59
RSI 40.88
Earnings Date Apr 29, 2025

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 519
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2024, Citi Pharma's revenue was 12.41 billion, an increase of 0.10% compared to the previous year's 12.40 billion. Earnings were 833.46 million, an increase of 26.67%.

Financial Statements

News

There is no news available yet.